What the article is saying:
Some big investors are betting that the price of Amgen's stock will go down. They are buying options that give them the right to sell Amgen's stock at a certain price, hoping that they can do so at a lower price in the future. This could be because they think Amgen's stock is overpriced or that there will be some bad news for the company soon. It is important to pay attention to what these big investors are doing because they often have better information than regular people and their actions can affect the stock price. Read from source...

- He criticizes AI for not providing specific examples of the "big money" options trades he is discussing, making it unclear how he is defining "big money" and "significant move."
- He points out that the options scanner mentioned in the article does not seem to be a reliable or well-known tool, as it does not appear on the Benzinga website or have any clear explanation of its purpose or function.
- He argues that the article's claim of a "bearish" sentiment among deep-pocketed investors is misleading, as the majority of the options trades mentioned are actually bullish calls, not bearish puts.
- He notes that the article's discussion of the volume and open interest trends is vague and unhelpful, as it does not provide any specific numbers or data to support its claims.
- He questions the credibility of the article's use of analyst ratings and price targets, as it cites only one analyst's opinion and does not provide any context or reasoning for its inclusion.
- He criticizes the article's focus on Amgen's performance and upcoming earnings announcement, as it does not directly relate to the options trades discussed earlier in the article.
- He argues that the article's attempt to create urgency and interest in the options trades is ultimately unconvincing and misleading, as it does not provide any clear or actionable information for readers.

Final answer: AI criticizes the article for being unclear, misleading, and unconvincing.

Detailed description of the investment strategy, including the rationale for each recommendation and the risks associated with it.

In conclusion, the analysis of Amgen's options activity reveals a divided sentiment among deep-pocketed investors. While some are bullish on the stock, others are bearish, which indicates that there may be significant price movements in the near future. This information is crucial for investors and traders who are looking to make informed decisions about their positions in Amgen. Keep an eye on this stock and consider adjusting your strategy accordingly to capitalize on potential opportunities or minimize risks.